Pantoprazol Aurobindo (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Aurobindo, is a proton pump inhibitor (PPI) presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related gastrointestinal conditions in adults and children.

GNH USA supplies Pantoprazol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Aurobindo is a proton pump inhibitor that addresses disorders linked to excess gastric acid secretion.

- Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine disorder.

Pantoprazol Aurobindo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: typically self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: kidney inflammation. - Severe hypersensitivity: rash, angio‑edema, anaphylaxis. - Osteoporotic fractures: increased risk with long‑term use. - Vitamin B12 deficiency: possible with prolonged therapy. - Hepatic injury: rare elevation of liver enzymes.

Before prescribing Pantoprazol Aurobindo, clinicians should consider several safety aspects.

- Assess renal function: dose adjustment may be required in severe impairment. - Review liver status: use with caution in hepatic disease. - Evaluate osteoporosis risk: long‑term therapy may affect bone density. - Monitor for infections: PPIs can increase susceptibility to gastrointestinal infections. - Pregnancy and lactation: weigh benefits against potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Aurobindo can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole oral suspension: reduced absorption due to higher gastric pH. - Atazanavir: markedly decreased plasma concentrations. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate (high dose): reduced renal clearance, watch for toxicity. - Digoxin: slight increase in serum levels, assess clinical response. - Iron supplements: decreased absorption, separate dosing times.